• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Herbalife Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    5/1/26 4:58:28 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email
    false 0001180262 0001180262 2026-04-29 2026-04-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): April 29, 2026

     

     

     

    Herbalife Ltd.

    (Exact Name of Registrant as Specified in Charter) 

     

     

     

    Cayman Islands   1-32381   98-0377871
    (State or Other Jurisdiction   (Commission File Number)   (IRS Employer
    of Incorporation)     Identification No.)

     

    P.O. Box 309, Ugland House    
    Grand Cayman    
    Cayman Islands   KY1-1104
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: c/o (213) 745-0500

     

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

     

    Title of each class

        Trading
    Symbol(s)
        Name of each exchange
    on which registered
    Common Shares, par value $0.0005 per share     HLF     New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

    Item 1.01 Entry into a Material Definitive Agreement.

     

    Senior Secured Notes due 2033

     

    On April 29, 2026, HLF Financing SaRL, LLC (“HLF Financing”) and Herbalife International, Inc. (“HII” and together with HLF Financing, the “Issuers”), each a wholly owned subsidiary of Herbalife Ltd., a Cayman Islands exempted company incorporated with limited liability (the “Company”), issued $800 million aggregate principal amount of 7.750% Senior Secured Notes due 2033 (the “Notes”) to certain initial purchasers (the “Offering”). The Notes were offered and sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The Notes are governed by an indenture, dated as of April 29, 2026, among the Issuers, the Company and certain subsidiaries of the Company party thereto as guarantors and Citibank, N.A., as trustee and notes collateral agent (the “Indenture”).

     

    The Notes will bear interest at a rate of 7.750% per year payable semi-annually in arrears in cash on May 1 and November 1 of each year, beginning on November 1, 2026. The Notes will mature on May 1, 2033.

     

    The Notes are jointly and severally, unconditionally guaranteed on a senior secured basis by the Company and its existing and future subsidiaries that are guarantors of the obligations of any domestic borrower under the Company’s senior secured credit facility. The Notes and the related guarantees are the Issuers’ and the guarantors’ senior obligations, and are secured on a first-priority basis by liens on the Collateral (as defined in the Indenture), which is the same collateral that secures the Company’s senior secured credit facility, subject to certain limitations and permitted liens, and are: (i) equal in right of payment with all of the Issuers’ and guarantors’ existing and future senior indebtedness; (ii) equal in priority as to the Collateral owned by the Issuers and guarantors with respect to any obligations of the Issuers and guarantors secured by a first priority lien on the Collateral, including under the Company’s senior secured credit facility; (iii) effectively senior to all existing and future indebtedness of the Issuers and guarantors that is unsecured or secured by junior liens on the Collateral, to the extent of the value of the Collateral owned by the Issuers or such guarantor; (iv) effectively subordinated to all of the Issuers’ and guarantors’ existing and future indebtedness that is secured by liens on assets that do not constitute a part of the Collateral, to the extent of the value of such assets; (v) senior in right of payment to any of the Issuers’ future indebtedness that is, by its terms, expressly subordinated in right of payment to the Notes, and (vi) structurally subordinated to all liabilities of the Company’s subsidiaries (other than the Issuers) that are not guarantors.

     

    At any time prior to May 1, 2029, the Issuers may redeem all or part of the Notes at a redemption price equal to 100% of their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest (subject to the rights of holders of record on the relevant record date to receive interest due on the relevant interest payment date). In addition, at any time prior to May 1, 2029, the Issuers may redeem up to 40% of the aggregate principal amount of the Notes with the proceeds of one or more equity offerings, at a redemption price equal to 107.750%, plus accrued and unpaid interest. Furthermore, at any time on or after May 1, 2029, the Issuers may redeem all or part of the Notes at the following redemption prices, expressed as percentages of principal amount, plus accrued and unpaid interest thereon to the redemption date, if redeemed during the twelve-month period beginning on May 1, of the years indicated below:

     

    Year  Percentage 
    2029   103.875%
    2030   101.938%
    2031 and thereafter   100.000%

     

    If certain change of control events occur, each holder of Notes will have the right to require the Issuers to repurchase all or any part of such holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount of Notes repurchased, plus accrued and unpaid interest, if any.

     

    1

     

    The Indenture contains customary negative covenants, including, among other things, limitations or prohibitions on restricted payments, incurrence of additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the Indenture contains customary events of default.

     

    The foregoing summary of the Indenture is not complete and is qualified in its entirety by reference to the complete text of the Indenture, which includes the form of the Note, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference.

     

    Senior Secured Credit Facility

     

    On April 29, 2026, the Company, HLF Financing, HII, Herbalife International Luxembourg S.à R.L., HBL IHB Operations S.à r.l., certain subsidiaries of the Company party thereto as guarantors, the lenders party thereto, each issuing bank, Citizens Bank, N.A., as collateral agent and Coöperatieve Rabobank U.A., New York Branch (“Rabobank”), as administrative agent for the lenders under the term loan A facility (the “Term A Facility”) and as administrative agent for the revolving credit facility (the “Revolving Credit Facility”), entered into a ninth amendment (the “Amendment”) to the Credit Agreement dated as of August 16, 2018 (as so amended, the “Credit Agreement”).

     

    The Amendment, among other things, refinanced and replaced in full the Company’s existing credit facilities with (i) the Term A Facility, with an aggregate principal amount of $225 million, and (ii) the Revolving Credit Facility, with an aggregate principal amount of $425 million (the refinancings effected pursuant to the Credit Agreement, together with the Offering, the “Refinancings”).

     

    The Term A Facility and Revolving Credit Facility bear interest at, depending on the Company’s total leverage ratio, either the Term SOFR plus a margin of between 2.5% and 3.25%, or the base rate plus a margin of between 1.5% and 2.25%. The base rate represents the highest of the Federal Funds Rate plus 0.50%, one-month Term SOFR plus 1.00%, and the prime rate quoted by The Wall Street Journal, subject to a floor of 1.00%. The Company will pay a commitment fee on the Revolving Credit Facility of, depending on the Company’s total leverage ratio, between 0.25% to 0.35% per annum on the undrawn portion of the Revolving Credit Facility. The Term A Facility and Revolving Credit Facility mature upon the earlier of (i) April 29, 2031, or (ii) December 16, 2027 if the outstanding principal on the Company’s convertible senior notes due 2028 exceeds $250.0 million and the Company exceeds certain leverage ratios as of that date, or (iii) December 1, 2028 if the outstanding principal on the Issuers’ senior notes due 2029 exceeds $300.0 million and the Company exceeds certain leverage ratios as of that date.

     

    The Credit Agreement contains affirmative, negative and financial covenants customary for financings of this type, including, among other things, limitations or prohibitions on declaring and paying dividends and other distributions, redeeming and repurchasing certain other indebtedness, loans and investments, additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the Credit Agreement contains customary events of default. The Term A Facility and Revolving Credit Facility require the Company to maintain a maximum total leverage ratio of 4.00:1.00, a maximum first lien net leverage ratio of 2.50:1.00, and a minimum fixed charge coverage ratio of 2.00:1.00.

     

    Borrowings under the Credit Agreement are jointly and severally, unconditionally guaranteed on a senior secured basis by the Company and certain of its existing and future subsidiaries.

     

    The foregoing summary of the Amendment is not complete and is qualified in its entirety by reference to the complete text of the Amendment a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

     

    The Company used the net proceeds from the Refinancings, including borrowings under the Revolving Credit Facility, and available cash, to repay the $365 million outstanding principal balance on its prior term loan B facility and to fully redeem the $800 million outstanding principal balance of the Issuers’ 12.250% Senior Secured Notes due 2029 (“2029 Secured Notes”), plus accrued and unpaid interest, and to pay related fees and expenses.

     

    2

     

    Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

     

    The information set forth under “Item 1.01. Entry into a Material Definitive Agreement” is incorporated herein by reference.

     

    Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.

     

    On April 14, 2026, the Issuers issued a conditional notice of full optional redemption to redeem all of the 2029 Secured Notes, conditioned upon the completion of one or more debt financing transactions and the receipt of aggregate gross proceeds by the Issuers of at least $800 million on or before April 29, 2026. The closing of the Offering on April 29, 2026 satisfied the condition precedent set forth in the notice of redemption such that the redemption occurred on April 29, 2026. The 2029 Secured Notes were issued under an Indenture, dated as of April 12, 2024, among HLF Financing, HII, the guarantors party thereto and Citibank, N.A., as trustee and notes collateral agent. The redemption price for the 2029 Secured Notes was equal to 106.125% of the principal amount plus accrued and unpaid interest to, but not including, the redemption date, an aggregate of approximately $852.8 million.

     

    Item 8.01. Other Events.

     

    On April 29, 2026, the Company issued a press release announcing the closing of the Refinancings.

     

    A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

      

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    4.1 Indenture, dated as of April 29, 2026 among HLF Financing SaRL, LLC and Herbalife International, Inc., the guarantors party thereto and Citibank, N.A., as trustee and notes collateral agent.
    4.2 Form of Global Note for 7.750% Senior Secured Notes due 2033 (included as Exhibit A to Exhibit 4.1 hereto).
    10.1 Ninth Amendment to Credit Agreement, dated as of April 29, 2026, by and among HLF Financing SaRL, LLC, Herbalife Ltd., Herbalife International Luxembourg S.à R.L., HBL IHB Operations S.à r.l., Herbalife International, Inc., certain of Herbalife Ltd.’s subsidiaries party thereto as subsidiary guarantors, the several banks and other financial institutions or entities party thereto as lenders, Coöperatieve Rabobank U.A., New York Branch, as administrative agent for the Term Loan A Lenders and administrative agent for the Revolving Credit Lenders, and Citizens Bank, N.A., as collateral agent.
    99.1 Press Release issued by Herbalife Ltd. on April 29, 2026.
    104 Cover Page Interactive Data File - The cover page from the Company’s Current Report on Form 8-K filed on May 1, 2026 is formatted in Inline XBRL (included as Exhibit 101).

     

    3

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Herbalife Ltd.
         
    May 1, 2026 By: /s/ John DeSimone
      Name:  John DeSimone
      Title: Chief Financial Officer

     

    4

     

     

    Get the next $HLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    1/6/2026$20.00Buy
    Maxim Group
    11/26/2025Hold → Buy
    Argus
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    More analyst ratings

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    SEC Filings

    View All

    SEC Form 144 filed by Herbalife Ltd.

    144 - HERBALIFE LTD. (0001180262) (Subject)

    5/11/26 4:12:44 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:28:47 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:23:43 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists

    Recognitions reflect consumer confidence in the company's quality, reliability, and wellness leadership across generations Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, has been named to three 2026 USA TODAY Most Trusted Brands lists, including Most Trusted Brands, Brands Most Trusted by Parents, and Brands Most Trusted by Senior Citizens. The recognitions reflect consumer confidence in Herbalife's science-backed products and commitment to supporting healthy, active lifestyles across generations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603147461/en/Herbalife Named to Three

    6/3/26 4:30:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast IDEAS Conference on Thursday, June 11, 2026 at 10:35 a.m. ET (7:35 a.m. PT). The live webcast will be available at the following link: https://event.summitcast.com/view/GAjb2PfaSPbv9ViGy3AtzN/ZC5vwyKUXDsTKS4G6iXFet A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter. Additional information regarding th

    6/2/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Roman DBDR Acquisition Corp. II Appoints Hunter Gary to Board of Directors and Al Basseri as Chief Technology Officer, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions

    Roman DBDR Acquisition Corp. II ("Roman DBDR" or the "Company") (NASDAQ:DRDB) today announced the appointment of Hunter Gary to its Board of Directors (the "Board") and Al Basseri as Chief Technology Officer, as the Company continues preparations to complete its previously announced business combination with ThomasLloyd Climate Solutions B.V. ("ThomasLloyd"), a vertically integrated sustainable energy and technology solutions provider (the "Proposed Business Combination"). "We are thrilled to welcome Hunter to the Board of Directors and Al as our Chief Technology Officer as we prepare to complete our business combination with ThomasLloyd," said Dixon Doll, Jr., Chairman and CEO of Roman D

    5/15/26 8:00:00 AM ET
    $AEP
    $CVI
    $DRDB
    Electric Utilities: Central
    Utilities
    Integrated oil Companies
    Energy

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Walsh Des claimed ownership of 50,000 shares (SEC Form 3)

    3/A - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:49:59 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Operating Officer Hicks Troy sold $619,556 worth of shares (48,377 units at $12.81), exercised 83,270 shares at a strike of $9.31 and covered exercise/tax liability with 72,626 shares, decreasing direct ownership by 80% to 9,706 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:50:19 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Commercial Officer Lamberti Frank sold $1,932,259 worth of shares (142,919 units at $13.52), decreasing direct ownership by 80% to 36,624 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:59:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Argus

    Argus upgraded Herbalife Nutrition from Hold to Buy

    11/26/25 7:50:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Financials

    Live finance-specific insights

    View All

    Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints

    Q1 Results in Line with Preliminary Results Announced on April 14 Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2026: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506758807/en/ "We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation." - Stephan Gratziani, CEO Highlights First Quarter 2026 Net sales of $1.3

    5/6/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced preliminary first quarter 2026 results. The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance Net sales growth on a constant currency basis2 of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA¹ on a reported basis at or above the high end of previously issued first quarter guidance First quarter 2026 guidance for each metric was previously issued on February 18, 2026. The Company's first quarter net sales outperformance was driv

    4/14/26 8:00:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce First Quarter 2026 Results on May 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/udjduiru Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BIe9234

    4/1/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    View All

    Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq

    Transaction accelerates Herbalife and Cristiano Ronaldo's commitment to scale personalized nutrition and wellness globally Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company focused on making health more accessible and actionable. The transaction advances Herbalife's vision of becoming a technology-enabled, data-driven health and wellness platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326423343/en/Herbalife to Expand Its Personalized Nutritional Supplement Capabilit

    3/26/26 6:30:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care